The PennZone

  • Home
  • Music
  • Entertainment
  • Marketing
  • Non-profit
  • Education
  • Technology
  • Event
  • Books

$280B Invested, Mental Health Worsens—CCHR Demands Audit and Accountability
The PennZone/10288888

Trending...
  • Bethany Nikitenko Appointed to Philadelphia Trial Lawyers Association Board of Directors
  • Why Baton Rouge's Humid Climate Can Contribute to Carpenter Ant Damage — J&J Exterminating Explains How to Protect Your Home
  • LiteracyNation's 3rd Annual Indie Author Book Fair
CCHR Demands Audit and Accountability
Expert declares mental health and psychiatry are in a tailspin. CCHR warns of psychiatric treatment risks, rising drug deaths, and poor psychiatric hospital outcomes requiring close scrutiny.

LOS ANGELES - PennZone -- Citizens Commission on Human Rights International, a leading mental health industry watchdog, is calling for a federal audit of the $280 billion spent annually on mental health services, citing decades of failed outcomes and lack of meaningful improvements. Additionally, as CCHR has been exposing since the 1990s, millions of dollars have been wasted on National Institute of Mental Health (NIMH)-funded behavioral and psychiatric research that has included studying whiptail lizards, insects, electric fish and $3.1 million spent on the "vocal learning" of birds. Despite this massive investment, mental health in the U.S. continues to decline. CCHR warns that billions are being squandered on treatment-caused harm, overlooked polypharmacy risks, and rising deaths linked to psychotropic drugs.

President of CCHR, Jan Eastgate, said, "One thing we cannot be thankful for this year is an improved mental health system. We must acknowledge the financial costs and the toll on patients' health caused by extremely poor therapy outcomes, lack of cures, and rising deaths. The industry is plagued by iatrogenesis—the phenomenon of the 'healer' causing harm."

According to TIME magazine, "The U.S. has reached peak therapy. Counseling has become fodder for hit books, podcasts, and movies. Professional athletes, celebrities, and politicians routinely go public with their mental health struggles….  But something isn't adding up. Even as more people flock to therapy, U.S. mental health is getting worse by multiple metrics. Suicide rates have risen by about 30% since 2000."[1]

More on The PennZone
  • OPUS Global Data Solutions Launches Food Trader Plus, Bringing Operational Control and Deal-Level Profit Visibility to Food Brokers
  • Phinge CEO DeMaio Unveils Speech to Congress: User Data Sovereignty vs Tech Surveillance Capitalism, Asserting Foundational 2021 App-Less Patents & IP
  • Michael Maertens Hired as Century Fasteners Corp. – Chief Financial Officer
  • LATO AI Software Innovations Expedite Inspections & Repair of Parking Lots for The Pavement Group
  • Built to Last: Why BSI Is Among the Nation's Fastest-Growing Companies, and One of Its Best Places to Work

Polypharmacy, the practice of prescribing multiple psychotropic drugs simultaneously, is alarmingly common. This approach often leads to harmful drug interactions. Among the most overprescribed drugs and dangerous drugs are benzodiazepines, commonly referred to as "benzos." From mid-February to mid-March of 2020, prescriptions for these increased by 34%. Within a few short weeks, patients can develop a physical dependence on them ending up worse off than before the medications, struggling with addiction and withdrawal. Benzos can also have serious side effects, including respiratory depression, which can cause death. Stanford psychiatrist Anna Lembke, lead author of a New England Journal of Medicine essay, calls our overprescribing and overuse of benzos a "hidden epidemic."[2]

Over 21 years (1999-2019), 51,446 psychotropic-drug-implicated deaths (where psychotropic drugs were a contributing cause of death) occurred, with the annual psychotropic-drug-implicated death rate increasing over 3.4 times from 0.40 to 1.37 per 100,000. During the same period, there were also 649,697 psychotropic drug overdoses.[3]

In psychiatry, iatrogenesis has traditionally been linked to complications of psychotropic drug treatment, Medical Xpress reports. "Current classification systems in psychiatry fail to consider the iatrogenic components of psychopathology related to behavioral toxicity [the negative effects of therapeutic levels of medication]." These drugs' "paradoxical effects, manifestations of tolerance (loss of clinical effect, refractoriness), withdrawal and post-withdrawal disorders, are increasingly common due to the widespread use of psychotropic drugs in the general population."[4] In other words, psychiatry often ignores the harmful side effects caused by psychiatric drugs, such as worsening mental health and withdrawal symptoms, which are becoming more common as these drugs are widely used.

There are at least 180 psychiatric drugs on the market, not including all generic versions. Some of the iatrogenic effects include irreversible movement disorders causing uncontrollable muscle contractions such as tardive dyskinesia (TD), akathisia and dystonia. TD occurs in 20%-50% of patients taking antipsychotics and is also linked to antidepressants, mood stabilizers and stimulants.[5]

More on The PennZone
  • Bent Danholm's The Architecture of Demand Reaches No. 2 in Amazon Real Estate Sales
  • Contracting Resources Group Named to Inc. 5000 for the Ninth Time
  • Nola Blue Records to Release John Németh's Illinois Central in March 2027
  • ImagineX Named to 2026 Inc. 5000 List of America's Fastest-Growing Private Companies
  • ASSIST Software Becomes One of the First European Companies Certified to ISO/IEC 42001

Some psychotropics are nearly six times more likely to drive the person taking them to suicide than those not taking them, while spending time in a psychiatric hospital can increase that risk of self-inflicted death by 44 times.[6]

Clinical Psychology Science and Practice reported there is considerable evidence of heightened suicide risk and other negative outcomes during and immediately following hospitalization. As such, psychiatric hospitalization is iatrogenic. Despite limited research demonstrating its effectiveness in reducing suicide risk, inpatient hospitalization remains a primary "treatment" (often legally mandated, or forced) for individuals with high risk of suicide.[7]

Stanton Peele, Ph.D., states that "The world of mental health and psychiatry is in a tailspin," and cites Insel's "own confessional professional memoir," admitting, "The U.S., a country that leads the world in spending on medical research, also stands out for its dismal outcomes in people with mental illnesses. Indeed, over the last three decades, even as the government invested billions of dollars in better understanding the brain, by some measures, those outcomes have deteriorated."[8]

Founded in 1969 by the Church of Scientology and renowned University of New York psychiatrist Prof. Thomas Szasz, CCHR is calling for a transparent audit of the funds allocated to psychiatric services and their outcomes, and mental health research under NIMH. This audit aims to identify the failed treatments and programs that have contributed to the worsening state of the nation's mental health system.

Sources:

[1] time.com/6308096/therapy-mental-health-worse-us/

[2] time.com/6280929/polypharmacy-dangers-essay/

[3] pmc.ncbi.nlm.nih.gov/articles/PMC8355085/

[4] medicalxpress.com/news/2019-07-iatrogenic-disorders-psychiatry-common-neglected.html

[5] www.ncbi.nlm.nih.gov/pmc/articles/PMC5472076/

[6] link.springer.com/article/10.1007/s00127-014-0912-2

[7] www.researchgate.net/publication/339741738_The_potential_iatrogenic_effects_of_psychiatric_hospitalization_for_suicidal_behavior_A_critical_review_and_recommendations_for_research

[8] peele.net/lib/americanpsychiatry.html

Contact
CCHR International
***@cchr.org


Source: Citizens Commission on Human Rights

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
  • Loud! OOH calls for prize draw advertising standards as £1.3bn category moves outdoors
  • Insurance for Braces Helps Make Treatment More Manageable for Pennsylvania Families
  • Black Ribbon Productions Launches With Fearless 2026 Horror Slate
  • Actor Dominic Pace Returns to Television and Film
  • Opteamix welcomes Girish Ramachandra to its leadership team as Senior Vice President of Client Services
  • Silicon Box Ships 500M Units at High Yield, Expands Production Capacity for Panel-Level Packaging
  • Bethany Nikitenko Appointed to Philadelphia Trial Lawyers Association Board of Directors
  • Why Baton Rouge's Humid Climate Can Contribute to Carpenter Ant Damage — J&J Exterminating Explains How to Protect Your Home
  • Meals on Wheels of the Greater Lehigh Valley Awarded $50,000 Grant from Harry C. Trexler Trust
  • RPR Promotes Emily Line to Chief Strategy Officer and Janine Sieja to Chief Product Officer
  • Kellyn Hosts Fourth Lehigh Valley Lifestyle Medicine Symposium
  • Expanding Beyond Space as New Drone Market Opportunities Accelerate Growth: Ascent Solar Technologies (N A S D A Q: ASTI)
  • Lauren Merrell, Dale Sorensen Real Estate, announces price improvement for an extraordinary island retreat
  • Portalz Publishes FES World First Architecture Introducing a New Cryptographic Platform
  • Racquet Club of Philadelphia appoints Michael J. Sofia as new General Manager
  • Cellofest Brings Free Cello Concerts and Community Events to Bethany Beach August 5–16
  • Blue Sky Capital Strategies, LLC awarded Leasing and Financial Services agreement with Premier Inc
  • Michael M. Thomas Expands Executive Leadership Across Central India Outreach and Royal Trinity School
  • Porter's Day Care Opens Doors to Brighter Futures

Popular on PennZone

  • Community Partnership Brings Live Theater to 150+ Young People
  • CCHR: Congressional Hearing Revives Lessons from MKULTRA Era – Why Past Psychiatric Human Rights Abuses Demand Vigilance Today
  • Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board
  • Philadelphia Community Invited to Unite for Praise-A-Thon Summer Concert Benefiting Cobbs Creek
  • Heritage at Manalapan Introduces Luxury Single-Family Homes with Exceptional Value in One of Monmouth County's Most Desirable Locations
  • Pacto Medical Wins Red Dot Design Concept Award 2026 for Slimshot® Compact Prefilled Syringe
  • The J. Wes Project Celebrates 11 Years of Love, Music & Inspiration
  • Stepping Off the Grid: Savista Retreat Announces New Experiential Packages in Jaipur for Travellers
  • Cogs and Marvel expands EMEA leadership team for next phase of growth
  • Allstream Energy Partners Returns as a Media Partner for the 2026 API Inspection & Mechanical Integrity Summit in San Antonio

Similar on PennZone

  • New Book Calls 'Sense of Belonging' the Missing Link in Student Success
  • KT Medical Staffing Addresses the Questions Families Forget to Ask Before Bringing Private Nursing Care Home
  • Private Autopsies Give Arizona Families Answers After Nursing Home and Care Facility Deaths
  • Phinge CEO DeMaio Unveils Speech to Congress: User Data Sovereignty vs Tech Surveillance Capitalism, Asserting Foundational 2021 App-Less Patents & IP
  • Michael Maertens Hired as Century Fasteners Corp. – Chief Financial Officer
  • Built to Last: Why BSI Is Among the Nation's Fastest-Growing Companies, and One of Its Best Places to Work
  • Contracting Resources Group Named to Inc. 5000 for the Ninth Time
  • Lineus Medical Elevates Leadership to Accelerate Growth After Breakthrough Clinical Results
  • Cuvo Health, the #1 White Label Telehealth Platform, Surpasses 300 Exclusive Providers Serving All 50 States
  • FDA Clears Major Regulatory Hurdle as Preservative-Free Ketamine Program Moves Within Reach of Commercialization: NRx Pharmaceuticals: (NAS DAQ: NRXP)
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us